Friday, November 13, 2026

Energy & Environment

2 articles

AI Bird Detection System Cuts Wind Turbine Deaths 95% Across Global Installations

AI Bird Detection System Cuts Wind Turbine Deaths 95% Across Global Installations

Boulder Imaging's IdentiFlight AI system reduces bird mortality at wind farms by over 95% while limiting energy losses to under 1%, addressing a key regulatory barrier to wind expansion worldwide. The computer vision platform detects protected species from 1.5 kilometers away, automatically curtailing turbines only when necessary. The technology's commercial deployment follows enterprise investment from Lime Rock New Energy.

LM Salvado•
Metallurgical Coal Faces 40% Demand Drop by 2040 as Hydrogen Steelmaking Spreads Globally

Metallurgical Coal Faces 40% Demand Drop by 2040 as Hydrogen Steelmaking Spreads Globally

Alpha Metallurgical Resources confronts 70% confidence climate transition risk as steel producers in Germany, Sweden, and China shift to hydrogen-based production that eliminates metallurgical coal use. Met coal prices fell 50% from $615 per ton in Q1 2022 to $310 in Q4 2025. EU carbon border mechanisms create €50-75 per ton cost advantage for hydrogen steel over traditional blast furnace methods.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com